Tag: inhaled nitric oxide

vero biotech GENOSYL® DS
COVID-19 Archive

FDA Grants GENOSYL® DS Expanded Access Emergency Use of Tankless iNO for Treatment of COVID-19

The recently FDA-approved GENOSYL® inhaled nitric oxide may have pulmonary and antiviral benefits in treating pulmonary hypertension and acute infectious diseases associated with the novel coronavirus1   VERO Biotech LLC, an Atlanta, Georgia-based biotechnology company focused on saving lives, alleviating suffering, and improving the health economics of care, announced that […]